BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17933205)

  • 1. Continuous microbiological air monitoring for aseptic filling lines.
    Ginsbury K
    PDA J Pharm Sci Technol; 2007; 61(4):225. PubMed ID: 17933205
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous microbiological air monitoring for aseptic filling lines.
    Scherwing C; Golin F; Guenec O; Pflanz K; Dalmaso G; Bini M; Andone F
    PDA J Pharm Sci Technol; 2007; 61(2):102-9. PubMed ID: 17479718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the BioVigilant IMD-A, a novel optical spectroscopy technology for the continuous and real-time environmental monitoring of viable and nonviable particles. Part II. Case studies in environmental monitoring during aseptic filling, intervention assessments, and glove integrity testing in manufacturing isolators.
    Miller MJ; Walsh MR; Shrake JL; Dukes RE; Hill DB
    PDA J Pharm Sci Technol; 2009; 63(3):259-83. PubMed ID: 20069799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some observations on airborne particles in the critical areas of a blow-fill-seal machine.
    Sundström S; Ljungqvist B; Reinmüller B
    PDA J Pharm Sci Technol; 2009; 63(1):71-80. PubMed ID: 19455943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panel discussion: environmental sampling in an aseptic environment. I. Microbiological environmental monitoring.
    Raiman HL
    Bull Parenter Drug Assoc; 1974; 28(6):253-60. PubMed ID: 4616742
    [No Abstract]   [Full Text] [Related]  

  • 6. Continuous Microbiological Environmental Monitoring for Process Understanding and Reduced Interventions in Aseptic Manufacturing.
    Weber J; Hauschild J; Ijzerman-Boon P; Forng RY; Horsch J; Yan L; Prasad A; Henry RB; Claassen M; Villari P; Shereefa S; Wyatt J; Bolden JS; Pycke JT; Dassu D
    PDA J Pharm Sci Technol; 2019; 73(2):121-134. PubMed ID: 30361285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panel discussion: Environmental sampling in an aseptic environment. III. Cross contamination control.
    Elias WF
    Bull Parenter Drug Assoc; 1974; 28(6):263-9. PubMed ID: 4455322
    [No Abstract]   [Full Text] [Related]  

  • 8. The biotest RCS air samplers in unidirectional flow.
    Ljungqvist B; Reinmüller B
    J Pharm Sci Technol; 1994; 48(1):41-4. PubMed ID: 8004418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous and Effective Microbiological Air Monitoring in Critical Environments: A Comparison of Analytical Methodologies.
    Dalmaso G; Campanella A; Lazzeri P
    PDA J Pharm Sci Technol; 2020; 74(4):446-455. PubMed ID: 32060221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aseptic work under various hygienic conditions.
    Aslund B; Olson OT; Sandell E
    Acta Pharm Suec; 1977; 14(5-6):517-24. PubMed ID: 596167
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of different incubation conditions for microbiological environmental monitoring.
    Gordon O; Berchtold M; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2014; 68(5):394-406. PubMed ID: 25336415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk management, cGMP, and the evolution of aseptic processing technology.
    Agalloco J; Akers J; Baseman H; Boeh R; Madsen R; Ostrove S; Pavell A
    PDA J Pharm Sci Technol; 2009; 63(1):8-10. PubMed ID: 19455938
    [No Abstract]   [Full Text] [Related]  

  • 13. [Microbiological aspects of the pharmaceutical environment].
    Buogo A; Guerrato G; Giulioni A; Papakristo G
    Boll Chim Farm; 1979 Jan; 118(1):9-17. PubMed ID: 454532
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the BioVigilant IMD-A, a novel optical spectroscopy technology for the continuous and real-time environmental monitoring of viable and nonviable particles. Part I. Review of the technology and comparative studies with conventional methods.
    Miller MJ; Lindsay H; Valverde-Ventura R; O'Conner MJ
    PDA J Pharm Sci Technol; 2009; 63(3):245-58. PubMed ID: 20069798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Blow/Fill/Seal process variables in determining rate of vial contamination by air dispersed microorganisms.
    Leo F; Poisson P; Sinclair CS; Tallentire A
    PDA J Pharm Sci Technol; 2005; 59(5):320-31. PubMed ID: 16316067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between air movements and the dispersion of contaminants: clean zones with unidirectional air flow.
    Ljungqvist B; Reinmüller B
    J Parenter Sci Technol; 1993; 47(2):60-9. PubMed ID: 8515346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contamination Control.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):232-8. PubMed ID: 26714364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methods for gathering and microbiological analysis of air in buildings].
    Bălan G
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(1-2):81-3. PubMed ID: 18441963
    [No Abstract]   [Full Text] [Related]  

  • 19. [Microbiological in-process control in drug manufacture].
    Seyfarth VH
    Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF; McKeon MR; Weiss WT
    Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.